What is RxSight Inc (RXST)?
RxSight Inc is a medical technology company specializing in the development and commercialization of intraocular lens systems designed to improve vision outcomes for patients undergoing cataract surgery. The company focuses on innovative solutions that enhance the quality of vision by allowing for postoperative adjustments to the lens, aiming to reduce dependence on glasses or contact lenses. Its products integrate advanced materials and proprietary technologies to address common visual impairments associated with cataracts. The company operates within the ophthalmic medical device sector, serving healthcare providers and patients globally. Research and development are central to its operations, with an emphasis on clinical validation and regulatory compliance to ensure safety and efficacy. The company’s offerings contribute to advancements in eye care by providing customizable vision correction options in surgical settings.
RxSight Inc Stock Price Today: Live Overview
The price today is shaped by ongoing market activity, with RxSight Inc currently at $6.79. It has fluctuated between $6.75 and $7.26, marking a daily change of -7.6607%.
FAQ: RxSight Inc (RXST)
What is the current price of RXST stock?
The current price is $6.79.
Does RXST pay dividends?
The company pays dividends via cash distributions (if applicable).
Does RXST have a formal corporate presence or regional headquarters in the UAE?
RxSight Inc operates via partners and distributors in the UAE and does not have an official regional office or subsidiary.
What is RXST best known for?
RxSight Inc is most famous for its intraocular lens technologies used in vision correction.
What assets are typically shown together with RXST?
Commonly shown alongside RXST: Friedrich Vorwerk Group SE, L&G Japan Equity UCITS ETF, Neogen Corp
Latest shares articles



